Načítá se...
Patient Preferences for the Chemoprevention of Esophageal Adenocarcinoma in Barrett’s Esophagus
OBJECTIVES: Although evidence suggests that aspirin and celecoxib may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus (BE), these drugs can also cause harmful side effects. Our aim was to determine and characterize preferences for these two drugs in patients w...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3736801/ https://ncbi.nlm.nih.gov/pubmed/18775019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1572-0241.2008.02117.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|